menu search

Electrocore expands intellectual property portfolio for non-invasive vagus nerve stimulation (nvns) technology

ROCKAWAY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, t...

October 11, 2023, 12:00 pm

Patient with candida krusei infection in matinas biopharma’s oral mat2203 expanded access program achieves complete clinical resolution

BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on de...

October 11, 2023, 11:30 am

Silk road medical stock plummets on ceo exit and revenue downgrade

Silk Road Medical (NASDAQ:SILK) stock halved in value at the start of Wednesday's trading after an after-hours profit warning. The company, which has ...

October 11, 2023, 10:58 am

Tiziana life sciences to present ms treatment at ectrims annual congress

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "Treatment Of...

October 11, 2023, 9:26 am

Vivos therapeutics to kick off clinical trial at stanford medicine

Vivos Therapeutics (NASDAQ:VVOS) Inc has announced that its flagship daytime-nighttime appliance (DNA) will be tested in a clinical trial at Stanford ...

October 11, 2023, 8:29 am

Labcorp launches 3-part blood test for alzheimer's

Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer's,...

October 11, 2023, 7:34 am

Altimmune: a year of disappointment

Altimmune's stock has disappointed shareholders over the past year, with disappointing trial results triggering a significant drop in equity in March ...

October 11, 2023, 3:46 am

An2 therapeutics to present new data for epetraborole at idweek 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing tre...

October 11, 2023, 12:01 am

Medicinova receives a notice of allowance for a new patent covering the combination of mn-166 (ibudilast) and riluzole for the treatment of amyotrophic lateral sclerosis (als) in canada

LA JOLLA, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...

October 10, 2023, 11:00 pm

Sellas receives fda orphan drug designation for sls009 for treatment of acute myeloid leukemia

NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clini...

October 10, 2023, 8:15 pm

Why shares of 89bio plummeted on tuesday

89bio is a clinical-stage biotech company. It focuses on treatments for liver and cardiometabolic disea...

October 10, 2023, 4:13 pm

Inovio shares rise after positive fda feedback on rrp treatment candidate

Biotechnology company Inovio saw its shares jump after the US FDA communicated that data from Inovio completed Phase 1/2 trial of INO-3107 for treatin...

October 10, 2023, 2:47 pm

Rayzebio: initiating coverage with buy rating and a price target of $43

Initiating RayzeBio, Inc. coverage with a Buy rating and common stock price target of $43 based on my risk-adjusted NPV discounted cash flow model, re...

October 10, 2023, 2:10 pm

Roche's (rhhby) vabysmo positive in late-stage rvo studies

Roche (RHHBY) Vabysmo maintains vision improvements with extended treatment intervals of up to four mon...

October 10, 2023, 1:32 pm

Cancer biotechs pique buyout interest: recent deals in focus

The M&A trend of 2023 shows that there is an increasing interest in biotech companies making innovative cancer tre...

October 10, 2023, 12:47 pm

Akero therapeutics inc stock tanks after nash liver treatment study disappoints

Akero Therapeutics Inc shares lost roughly two-thirds of their value Tuesday morning after the company released a disappointing update on its fatty li...

October 10, 2023, 11:51 am

Biotech stock sinks after disappointing trial

Akero Therapeutics Inc (NASDAQ:AKRO) is plummeting to 52-week lows, after its treatment for severe fatt...

October 10, 2023, 11:18 am

Annexon announces clinical and regulatory progress for anx005 pivotal program in guillain-barré syndrome (gbs)

ANX005 Granted Orphan Drug Designation by the European Medicines Agency for the Treatment of GBS Target...

October 10, 2023, 10:30 am

Merck immunotherapy shows further promise in lung cancer

Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a phase III clinical trial,  showi...

October 10, 2023, 9:11 am

Filament health says health canada authorizes phase 2 clinical trial studying botanical psilocybin for opioid use disorder

Filament Health Corp (OTCQB:FLHLF, NEO:FH) told investors that Health Canada has approved a phase 2 clinical trial of its botanical psilocybin drug ca...

October 10, 2023, 8:21 am


Search within

Pages Search Results: